8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors
US7482456B2 · kind B2 · utility
3Cited by
3References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2004 |
| Grant date | Jan 27, 2009 |
| Priority date | — |
| Expiry date | Dec 13, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel substituted 8-phenylquinolines represented by Formula (I), wherein the phenyl group at the 8-position contains an aryl or heteroaryl substituent in the meta position, are PDE4 inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.